The expression status of SOX17 was first evaluated in normal human cervix (NC), high-grade squamous intraepithelial lesion (HSIL) and cervical cancer (CC) samples by immunohistochemistry (IHC). This evidence concerns the gene SOX17 and cervical carcinoma.